Connect with us

Technology

Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios

Published

on

Built on an award-winning AI foundation, Medidata Plus removes traditional barriers, empowering sponsors and CROs to scale intelligence across entire portfolios

SINGAPORE, July 30, 2026 /PRNewswire/ — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today announced the launch of Medidata Plus. This clinical artificial intelligence layer unlocks the full breadth of AI capabilities across the Medidata Platform, giving sponsors access to scalable, outcome-driven AI throughout their global portfolios. Medidata Plus shifts the life sciences industry away from a legacy of disjointed, inefficient point solutions to a unified, end-to-end AI strategy, accelerating the delivery of life-saving therapies to patients.

While 92% of industry decision-makers plan to increase AI investment, only 29% say AI currently meets or exceeds their expectations. Medidata Plus addresses these systemic roadblocks directly, turning unpredictable AI costs into a streamlined, predictable investment by standardizing the data layer across the entire clinical trial lifecycle.

“Stitching together point solutions isn’t a strategy — it’s a liability. Drug development’s next leap will come when AI is consistent, connected, and portfolio-wide,” said Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology, IDC. “Medidata Plus delivers this with a cohesive AI layer across the entire lifecycle, shifting organizations from sporadic AI adoption to a continuous, portfolio-wide strategy that drives real clinical outcomes.” 

Medidata Plus brings AI-driven intelligence to every stage of a clinical trial, from study build to data management to ongoing risk monitoring. Rather than relying on a patchwork of disconnected tools, study teams can access a single, unified layer of AI capabilities built to accelerate execution and surface insights in real time. Key capabilities made accessible through Medidata Plus include:

Study Builds Accelerated with AI: Reduces study build timelines from weeks to mere hours by automating EDC and eCOA design, and generating synthetic patient data for user acceptance testing, dramatically accelerating study startup times.No-Code Data Transformation: Through enhanced AI interoperability, Medidata Plus seamlessly ingests, standardizes, and transforms data from clinical and real-world sources to extract insights without writing a single line of code.Proactive De-risking: Embedded analytics instantly flag critical enrollment downtrends or safety signals, reducing mid-cycle pauses and accelerating inspections.Companioning Audit Exploration: Agentic AI supports study teams to mine their end-to-end audit history using natural-language queries, transforming complex regulatory data into actionable insights in minutes.

“We’ve listened to our customers and they’re clear that AI can transform clinical trials, but not as an army of agents from disparate sources trained in disparate ways,” said Anthony Costello, CEO, Medidata. “Medidata Plus is a drop-in AI strategy for clinical research that upskills teams, automates workflows, and surfaces insights at a pace that’s redefining what teams thought was possible. We are in conversations with dozens of customers about making this shift and what we’re hearing tells us the industry has been waiting for exactly this.”

Life sciences organizations, ranging from enterprise biopharma leaders to global CROs, are poised to unlock significant value through Medidata Plus, which provides them with a decisive technological edge to execute clinical trials with greater precision, higher quality, and accelerated timelines. 

The launch of Medidata Plus establishes a future-ready framework for platform advancement. As Medidata continues to embed clinically-fluent AI across its ecosystem, study teams from sponsors and CROs will gain access to an expanding suite of capabilities that deliver value across their trial portfolios.

Backed by an AI infrastructure recently recognized with the highest “Luminary” rating in Everest Group’s AI Innovation Watch Report, Medidata’s AI continues to set the standard in clinical trials, having supported 80% of FDA novel drug approvals in 2025. To learn more about how Medidata Plus delivers an easy, fast, and AI-powered clinical research experience, visit here

About Medidata 

Medidata has been powering smarter treatments and healthier people by supporting clinical trials through groundbreaking technological innovations for over 25 years. Medidata is a leader in AI-powered solutions across the entire trial lifecycle to accelerate clinical breakthroughs, reduce patient and site burden, and bring new therapies to market faster. Supported by one of the largest clinical datasets in the industry of more than 38,000 trials and 12 million patients, Medidata’s Study, Patient, and Data Experiences are trusted by more than 1 million registered users across approximately 2,300 customers. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and is recognized as a leader by Everest Group and IDC. Discover more at www.medidata.com. Listen to our latest podcast, from Dreamers to Disruptors, and follow us at @medidata-solutions on LinkedIn. 

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. Through the 3DEXPERIENCE platform, AI-powered, science-based virtual twins help 390,000 customers of all sizes, in all industries, collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: www.3ds.com

Contact:  

For interviews and questions, please contact Medidata PR 

Medidata.PR@3ds.com  

Analyst Relations 

Medidata.AR@3ds.com  

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/medidata-launches-medidata-plus-an-ai-native-foundation-built-to-scale-clinical-portfolios-302838472.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Creality Launches SPARKX i7 Nano: Bringing Compact Multi-Color Printing to $299

Published

on

By

HOUSTON, Aug. 15, 2026 /PRNewswire/ — Creality, a global leader in the 3D printing industry, today announced the availability of the SPARKX i7 Nano, the latest addition to its i7 series. This desktop 3D printer saves space while delivering premium print quality across up to four colors. With a minimalist design that fits easily on a desk, the i7 Nano makes multi-color 3D printing more compact, affordable, and accessible.

Following the January debut of the i7 Color Combo, the i7 Nano is also built for smarter, more effortless 3D printing. It integrates AI-powered capabilities that simplify both creation and printing, including CubeMe for automatically turning 2D portraits into multi-color 3D models. A built-in 720p AI camera monitors prints for common failures such as spaghetti and air printing, while vibration compensation and dynamic pressure adjustment help maintain consistent print quality.

Beyond these shared features, the i7 Nano comes with an integrated spool holder and optimized filament layout, taking up less desktop space and making it easier to fit into compact workspaces. The spool holder mounts directly onto the printer body with a convenient snap-on design, eliminating the need for an external CFS Lite. This compact solution keeps the printer’s footprint small while maintaining a clean appearance without compromising printing performance.

Paired with the new CFS nano Kit, a small unit mounted on top of the printer, the i7 Nano enables vibrant multi-color printing with automatic filament switching for up to four colors. The CFS nano features a dual-motor system, with one motor controlling filament channel switching and the other handling filament feeding and retraction. This ensures smooth and efficient color changes while keeping the overall setup streamlined. The CFS nano also allows quick installation without complex disassembly or modifications and is compatible with existing i7 units.

The i7 Nano features a build volume of 260 × 260 × 255 mm and a maximum printing speed of up to 500 mm/s. It supports a hardened steel nozzle with a maximum temperature of 300°C and multiple nozzle diameters, including 0.2, 0.4, 0.6, and 0.8 mm. It is also equipped with automatic bed leveling, RFID filament reading and automatic filament refill to deliver an easy-to-use and reliable printing experience for beginners.

The SPARKX i7 Nano with CFS nano Kit will be available starting from August 15 for $299 in the U.S. at the Creality US Store.

View original content to download multimedia:https://www.prnewswire.com/news-releases/creality-launches-sparkx-i7-nano-bringing-compact-multi-color-printing-to-299-302851758.html

SOURCE Creality

Continue Reading

Technology

CATL and Quinbrook Build on Supernode Partnership Following Stage 2 and Stage 3 Major Milestones

Published

on

By

BRISBANE, Australia, Aug. 15, 2026 /PRNewswire/ — Quinbrook’s Supernode battery energy storage project has completed Stage 2 commercial operation and reached financial close on A$469 million financing for Stage 3, marking a further milestone in the phased development of Australia’s largest operational BESS campus.

With planned capacity expected to exceed 3 GWh, Supernode is supported by CATL as its core energy storage system supplier for all three stages, providing advanced storage solutions and lifecycle support to enable reliable long-term operation.

Located at Brendale, north of Brisbane, Supernode is adjacent to the South Pine substation, a key hub in the Queensland power system and the regional reference node for marginal loss factors (MLFs). This location provides a favourable MLF position and approximately 4,000MW of available connection capacity for phased expansion. The project’s development coincides with Queensland’s accelerating energy transition and the infrastructure investment cycle.

Stage 3 has reached financial close on A$469 million in debt financing, bringing total project financing across Supernode Stages 1, 2 and 3 to approximately A$1.2 billion. Across its first three stages, Supernode is set to reach 780MW / 3,074MWh. Capacity across the three stages has been contracted under long-term offtake arrangements. 

The long-term value of such assets depends on the continued availability, operational efficiency, safety and reliability of their energy storage systems. CATL has provided EnerC Plus systems for Stages 1 and 2 and will supply TENER S systems for Stage 3, establishing a consistent technology platform across the campus.

In close collaboration with Quinbrook, CATL has supported project-specific design optimisation to enable high-density deployment within the constraints of available industrial land. EnerC Plus supports back-to-back installation, reducing the required site footprint by approximately 20% compared with EnerC. Its integrated liquid-cooling system maintains an internal container temperature differential within 5°C and is designed to deliver reliable operation over a 20-year lifecycle.

CATL’s contribution extends beyond equipment supply. Under a Long-Term Service Agreement (LTSA), CATL will further support the full lifecycle of the energy storage asset through condition monitoring, performance tracking, fault response and preventive maintenance to help ensure reliable long-term operation. CATL’s proven product performance, scalable delivery capabilities and lifecycle service model provide greater confidence in the long-term reliability and performance of the energy storage asset.

Tim Hornemand, Managing Director and Regional Lead, Australia, at Quinbrook, said:
“Achieving commercial operations for Stage 2 means we’ve successfully delivered both Origin-contracted stages on schedule, an outcome we’re incredibly proud of given the complexity of commissioning utility-scale battery storage projects in Australia. With Stage 3 now fully financed, we’ve reached another important milestone in Supernode’s continuing development. The ongoing support of our banking partners also reflects confidence in the Supernode project, our delivery track record and the long-term outlook for battery storage in Australia.”

Tan Libin, CCO and Co-President of Sales & Marketing at CATL, said:
“Energy storage is evolving from a standalone technology deployment into a strategic energy asset. The next stage of industry development will depend not only on technological advancement, but also on the ability to create long-term value through collaboration, innovation and scalable deployment. At CATL, we are committed to working with partners to unlock the full potential of energy storage assets and support the transition toward a more flexible and resilient energy system.”

CATL and Quinbrook are also working together on EnerQB, an eight-hour battery storage solution being considered for future stages of the Supernode development. The initiative builds on CATL’s role as energy storage system supplier across Supernode’s first three stages. CATL will continue to work with partners worldwide to deliver reliable technologies, scalable solutions and lifecycle support.

SOURCE CATL

Continue Reading

Technology

Nocpix Nature Launches Rovex, a Large-Screen Thermal Solution for Faster Bird Discovery

Published

on

By

LONDON, Aug. 15, 2026 /PRNewswire/ — Nocpix Nature today introduced Rovex, a lightweight large-screen handheld thermal imaging camera designed to help birdwatchers, wildlife observers, and outdoor nature enthusiasts find birds more easily in challenging viewing conditions.

Rovex brings a new approach to bird search by combining a 5-inch large display, wide-field thermal imaging, and AI-assisted tracking in a lightweight handheld design. Rather than replacing binoculars or other birdwatching optics, Rovex is designed to help users locate birds faster when low light, dense vegetation, or complex surroundings make visual searching more difficult.

A Wider View for Faster Bird Discovery

Finding a bird is often the first challenge. Rovex’s 5-inch screen and 17.5° × 13.1° field of view allow users to scan a broader area with each sweep while viewing thermal information on a larger display. The open viewing experience makes it easier to search for potential wildlife activity without being confined to a narrow viewing window.

AI-Assisted Search for Faster Discovery

Rovex’s AI Smart Tracking helps highlight potential bird heat sources and guide attention toward areas of interest. By supporting the search process rather than simply displaying thermal imagery, Rovex helps birdwatchers identify where to look and spend less time scanning areas where nothing is happening.

Thermal Imaging When Nature Gets Harder to See

When birds blend into dense cover or become difficult to spot as light fades, thermal imaging can provide another way to search. Rovex combines a 384 × 288 @ 12μm thermal sensor with advanced image processing, including R+ Super-Resolution, smart denoising, and target highlighting, to help thermal signatures stand out against complex backgrounds.

With a lightweight design of less than 290g, Rovex is built for comfortable outdoor use and extended searching. It gives birdwatchers a practical tool for finding wildlife that might otherwise go unnoticed.

Rovex marks Nocpix Nature’s first step toward making wildlife observation smarter, easier, and more rewarding — Smart Ways to Discover.

About Nocpix Nature

Nocpix Nature is designed for birdwatchers and nature enthusiasts seeking more from their outdoor experiences. Powered by proprietary sensor technology and advanced AI image algorithms, Nocpix Nature develops intelligent, user-friendly observation tools that make it easier to discover, identify, record, and share wildlife moments. We believe observation goes beyond simply seeing—it is about building a more meaningful relationship with the natural world.

For further information:
Nocpix Nature Marketing Team
Email: info@nocpixnature.com
Website: www.nocpixnature.com

View original content:https://www.prnewswire.com/news-releases/nocpix-nature-launches-rovex-a-large-screen-thermal-solution-for-faster-bird-discovery-302852250.html

SOURCE Nocpix Nature

Continue Reading

Trending